The first step in gonadotropin-releasing hormone (GnRH) action involves the binding of GnRH to a plasma membrane receptor. Calcium has been implicated as a second messenger molecule. More recently, it has been suggested that the products of phosphoinositide metabolism may act as a second messenger for GnRH-stimulated release of luteinizing hormone (LH). To be considered a second messenger, however, a candidate molecule must meet three requirements: in the second messenger's presence, (a) GnRH should stimulate increased production of inositol phosphate; (b) inositolphosphate production, stimulated by any means, should provoke LH release; and (C) inhibition of inositol phosphate production should block GnRH-stimulated release of LH.
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Indexing Terms: hormones . calcium . phospholipase C luteinizing hormone . diseases of the reproductive system gonadotropes . protein kinase C Gonadotropin-releasing hormone (GnRH) is synthesized and stored in the medial basal hypothalamus.2 The peptide is released into the hypophyseal portal circulation, travels to the anterior pituitary gland, and binds to receptors on target cells known as gonadotropes. In response to stimulation by GnRH, the gonadotrope releases the gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone into the systemic circulation. These bind to receptors located in the gonads of both males and females and regulate gamete maturation and steroidogenesis. In a feedback mechanism, steroids and peptides produced by the gonads travel through the circulation and can act to modi1r hypotha- 
Role of Calcium in GnRH Action
Ca2 acts as a second messenger in GnRH-stimulated LII release. Using the fluorometric reagents Quin-2 and Fura-2 to measure intracellular Ca2, we observed that (1, 54 In another study (80) , NaF was used to stimulate G proteins in pituitary cell cultures. Fluoride activates G proteins by complexing with aluminum ion (which is found as a contaminant in glass and most saline solutions) to form an A1F4 complex (81) (82) (83) (84) . This complex can bind to the GDP on the a-subunit of the G protein and function as the -y phosphate, thereby mimicking activation by GTP/GDP exchange. The a-subunit can then dissociate from the fry-subunit to produce the active form of the G protein.
Treatment of pituitary cell cultures with NaF produced time-and concentration-dependent increases in both LII release and inositol phosphate production (80) . Although NaF can also act as a phosphatase inhibitor (85), NaF-stimulated release of LII and production of inositol phosphate did not appear to be a result of metabolic inhibition because other phosphatase inhibitors (molybdate, vanadate) did not stimulate either LH release or inositol phosphate production. Likewise, NaF-stimulated LII release and inositol phosphate production were unlikely to be a result of the increase in salt or Na concentration because equimolar concentrations of NaCl did not stimulate release of LH or production of inositol phosphate.
In comparing NaF-stimulated and GnRH-stimulated release of LII, the dependence of NsF-stimulated LII release on the activity of PKC was evaluated (54 Ca2 and then stimulated with increasing concentrations of NaF. LII release in response to NsF stimulation was unaffected by chelation of extracellular Ca2. This is in contrast to GnRH-stimulated LH release, which is blocked by pretreatment with EGTA (35) . However, the possibility remained that NaF activated a G protein that stimulated PLC hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) to inositol 1,4,5-triphosphate (JP3) and diacylglycerol. In theory, IP3 could then provoke mobilization of Ca2 from intracellular stores, resulting in increased amounts of free intracellular Ca2 and thereby stimulating LII release.
This model is unlikely to be correct, however: although NsF-stimulated release of UI is not affected by chelation of extracellular Ca2, NaF-provoked production of inositol phosphate is blocked by EGTA (86) . Therefore, after chelation of extracellular Ca2, NsF can stimulate LII release even though production of inositol phosphate is blocked. This implies that activation of G protein can stimulate UI release through a pathway independent of inositol phosphate production.
Role of G Proteins in Regulationof Gonadotrope

Responsiveness
Evidence of multiple sites of G protein action was produced in a study that assessed the role of G proteins in regulation of gonadotrope responsiveness (86) . That study reported pretreatment of pituitary cell cultures for 3 h with NaF, 10 mmol/L, decreased gonadotrope responsiveness to subsequent stimulation with GnRH. In contrast, the same pretreatment provoked an increase in gonadotrope responsiveness to the Ca2 ionophore A23187.
The G proteins responsible for stimulating these two effects were then further characterized on the basis of dependence on PKC activity and cAMP. In cells depleted of PKC, NaF pretreatment still provoked gonadotrope desensitization to GnRH, but did not stimulate gonadotrope sensitization to A23187. Furthermore, when cells were pretreated with dibutyryl cAMP (5 h, 1 mmollL), the A23187-stimulated release of LII was markedly enhanced. This enhancement was nonadditive with the enhancement provoked by NaF pretreatment, suggesting that G protein activation may stimulate enhanced gonadotrope responsiveness to A23187 by increasing intracellular concentrations of cAMP. In contrast, the same pretreatment with dibutyryl cAMP did not affect subsequent GnRH-stimulated release of UI. These results suggest that the gonadotrope desensitization to GnRH and the gonadotrope sensitization to A23187 provoked by NaF pretreatment are caused by distinct sites of G protein action. One site sensitizes the gonadotrope to A23 187, is dependent on PKC activity, and can be mimicked by increasing intracellular concentrations of cAMP, whereas another site desensitizes the gonadotrope to GnRH, is independent of PKC activity, and is not mimicked by increasing intracellular cAMP.
GnBH pretreatment
(5 h, 10 nmol/L) also provoked PKC-independent desensitization of the gonadotrope to subsequent GnRH stimulation, and sensitized the gonadotrope to subsequent A23 187 stimulation. Similarly to NsF pretreatment, GnRH pretreatment also decreased GnRH-stimulated release of UI in PKC-depleted cells, but did not sensitize the gonadotrope to A23187 in PKC-depleted cells. Because these effects have dependencies on PKC activity and cAMP similar to the effects provoked by G protein activation, we think GnRH may regulate gonadotrope responsiveness through activation of G proteins. In addition, there appears to be more than one site of G protein action in the gonadotrope because G protein activation desensitizes cells to GnRH yet sensitizes cells to A23187. Furthermore, these actions can be dissociated on the basis of dependence on PKC activity and cAMP.
Role of G Proteins in Regulation of the GnRH Receptor
In addition to the effects of prolonged G protein activation on UI release, NaF pretreatment also decreased the number of GnRH receptors and increased the affinity of the GnRH receptor for its agonist (86) . In pituitary cell cultures pretreated with 10 mmol/L NaF for 3 h, the binding of the GnRH receptor to buserelin decreased by 30% compared with the control. However, the affinity of the GnRH receptor for agonist increased after 3 h of NsF pretreatment. By comparison, the affinity of receptors for agonist characteristically decreases after acute activation of G protein. This has also been observed in the gonadotrope when GTP, GTP analogs, or NsF (76, 86) is used to stimulate the gonadotrope acutely. Therefore, prolonged G protein activation apparently provokes effects different from those provoked by acute stimulation. Thus, G protein activation may be involved in regulation of the GnRH receptor, gonadotrope responsiveness, and production of inositol phosphate.
Role of InositolPhosphate Production in LH Release
GnRH stimulation of pituitary cell cultures increases PLC-type hydrolysis of PIP2 to 1P3 and diacylglycerol. GnRH provokes increased incorporation of [32P] orthophosphate into phosphatidylinositol and phosphatidic acid (87, 88) In that study, the compound 1-(6-{[17/3-3-methoxyestra-1 ,3,5(10 GnRH-stimulated release of LII occurs in two phases (99) . The initial phase (<10 mm) is transient and depends on Ca2 mobilization from intracellular stores. The later phase is more prolonged (3 h) and depends on the influx of extracellular Ca2. The preliminary studies with U-73122 utilized static cell cultures and LII release was determined after 3 h of stimulation. Therefore, even if the initial phase of LH release was affected by U-73 122 pretreatment, this inhibition might not have been detectable when both prolonged and acute release of UI were measured together (i.e., after a 3-h incubation). Because inositol triphosphate stimulates mobilization of Ca2 from intracellular stores and because the initial phase of LH release is dependent on Ca2 from intracellular stores, a model was needed to measure specifically the initial phase of LH release. To accomplish this, a perifusion system was used in which cells could be exposed to pulsatile administration of GnRH (for 5 mm every 15 or 30 mm). With each pulse of GnRH, LII was released from the gonadotrope in both control cells and in cells pretreated with U-73 122 (31).
Thus, inositol phosphate production apparently
is not required for either the acute phase or the prolonged phase of GnRH-stimulated release of LII. In addition, the effect of PLC inhibition on GnRH- The effect of U-73122 and U-73343 pretreatment on NaF-stimulated production of inositol phosphate and release of LII has also been assessed. Similarly to GnRH, NaF-provoked production of inositol phosphate was blocked by pretreatment with U-73 122 but not U-73343. NaF-stimulated release of LII, however, was not inhibited by pretreatment with either U-73 122 or U-73343, providing further evidence that LH release can be uncoupled from production of inositol phosphate. In addition, these results support the view that there are multiple sites of G protein action in the gonadotrope. One site appears to be involved in provoking inositol phosphate production, whereas another site appears to be capable of stimulating LII release independently of PLC activity.
Effect of NaF Pretreatmenton Subsequent Production of InositolPhosphate
The effect of prolonged G protein activation on subsequent production of inositol phosphate in the gonadotrope has also been studied. Cells were pretreated with EGTA or with 10 mmol/L NaF plus EGTA for 3 h; under these conditions, NaF pretreatment still affected the GnRH-and A23 187-stimulated release of LII, but inositol phosphate production was blocked during the pretreatment. Subsequently, cells were stimulated with GnRH or NaF for 45 mm and the production of inositol phosphate was determined. NaF pretreatment completely inhibited both GnRH-and NaF-provoked production of inositol phosphate. Although NsF pretreatment decreased the subsequent GnRH-stimulated release of LII, the results are further evidence for uncoupling the GnRH-stimulated release of LH from inositol phosphate production, because GnRH still stimulates LII release to -70% of the maximum values. Likewise, NaF-stiinulated release of LH can also be uncoupled from inositol phosphate production by NaF pretreatment. NaF-stimulated release of LII was not decreased after NaF pretreatment, but inositol phosphate production was completely blocked. This is additional compelling evidence for the existence of multiple sites of G protein action in the gonadotrope. In this case, one site appears responsible for stimulation of inositol phosphate production, whereas a distinct site is capable of provoking U! release independently of inositol phosphate production.
Time Course of Recovery from NaF-Provoked Changes in Gonadotrope Responsiveness
It could be argued that the decrease in GnRH-stimulated release of LH observed after NaF pretreatment was due to the blockade of GnRH-provoked production of inositol phosphate. This is unlikely, however, because when cells were allowed to recover from NaF pretreatment, GnRH-provoked release of LII returned to control amounts within 6 h (100) . In contrast, GnRH-provoked production of inositol phosphate was still completely inhibited by NaF pretreatment after 6 h and did not 
Role of Inositol Phosphate Production in GnRH-Provoked Desensitization
The role of inositol phosphate production in GnRHprovoked desensitization to subsequent GnRH stimulation has also been assessed (80). Pituitary cell cultures were pretreated with 10 nmol/L GnRH for 5 h. Subsequently, cells were treated with GnRH for 3 h and the LII release was determined, or cells were treated for 45 mm and the production of inositol phosphate was measured. GnRH-stimulated UI release was decreased (1 mol/L GnRH stimulated release of 36.4% of cellular U! in control cells compared to 27.4% in GnRH-pretreated cells), but production of inositol phosphate was unaffected by GnRH pretreatment.
In addition, when inositol phosphate production was blocked by the PLC inhibitor U-73122, GnRH pretreatment still inhibited subsequent GnRH-stimulated LII release compared to control. Therefore, it appears that neither GnRH-nor NaF-provoked desensitization requires the production of inositol phosphate.
Summary
From recent studies, it appears that multiple G proteins are involved in GnRH actions in the gonadotrope. Activation of G protein stimulates UI release and inositol phosphate production in the gonadotrope in a time-and dose-dependent manner. However, both NaFand GnRH-stimulated release of UI can be uncoupled from inositol phosphate production because 11-73122 and NsF pretreatment block subsequent
GnRH-and
NaF-stimulated production of inositol phosphate but UI release still occurs. There also appears to be G protein involvement in regulation of gonadotrope responsiveness to secretagogues. NsF pretreatment decreases subsequent GnRH-stimulated release of UI, enhances subsequent A23 187-stimulated release of LII, decreases GnRH-receptor binding, and completely blocks GnRHprovoked production of inositol phosphate. Distinct sites of G protein action may be responsible for these various effects because the time courses of recovery from these effects differ. Furthermore, it appears that distinct G 
